9. DapaTAVI Trial : Dapagliflozin was superior to standard care alone in decreasing rates of all-cause mortality or worsening heart failure (HF) in older adults with aortic stenosis undergoing TAVI, resulting in a 28% relative risk reduction
6. RIVAWAR Trial : Rivaroxaban was found to be as effective and safe as warfarin in resolving post myocardial infarction (MI) left ventricular (LV) thrombus at three months.